Evidence for an intact polysaccharide capsule in Bordetella pertussis

Microbes and Infection

Volumn 12, Issue 3, 2010, Pages 238-245

  Neo, YiLin ^a   Li, Rui ^a   Howe, Josephine ^a   Hoo, Regina ^a   Pant, Aakanksha ^a   Ho, SiYing ^a   Alonso, Sylvie ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; GENOME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROCAPSULE; NONHUMAN; OPERON; PATHOGENESIS; PERTUSSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRULENCE;

ANIMALS; BACTERIAL ADHESION; BACTERIAL CAPSULES; BORDETELLA PERTUSSIS; CELL LINE; COMPLEMENT SYSTEM PROTEINS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; PHAGOCYTOSIS;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS; MAMMALIA;

EID: 76549135299     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.12.002     Document Type: Article

References (30)

1. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem. 75 (2006) 39-68
2. Campos M.A., Vargas M.A., Regueiro V., Llompart C.M., Alberti S., and Bengoechea J.A. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 72 (2004) 7107-7114
3. Raffatellu M., Chessa D., Wilson R.P., Tuckel C., Akcelik M., and Bäumler A.J. Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect. Immun. 74 (2004) 19-27
4. Stokes R.W., Norris-Jones R., Brooks D.E., Beveridge T.J., Doxsee D., and Thorson L.M. The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages. Infect. Immun. 72 (2004) 5676-5686
5. Reckseidler-Zenteno S.L., DeVinney R., and Woods D.E. The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect. Immun. 73 (2005) 1106-1115
6. Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr. Top. Microbiol. Immunol. 306 (2006) 251-258
7. World Health Organization (WHO). http://www.who.int/en/
8. Bamberger E.S., and Sugro I. What is new in pertussis?. Eur. J. Pediatr. 167 (2008) 133-139
9. He Q., and Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 3 (2008) 329-339
10. Locht C. Molecular aspects of Bordetella pertussis pathogenesis. Int. Microbiol. 2 (1999) 137-144
11. Cotter P.A., and Jones A.M. Phosphorelay control of virulence gene expression in Bordetella. Trends Microbiol. 11 (2003) 367-373
12. Jones A.M., Boucher P.E., Williams C.L., Stibitz S., and Cotter P.A. Role of BvgA phosphorylation and DNA binding affinity in control of Bvg-mediated phenotypic phase transition in Bordetella pertussis. Mol. Microbiol. 58 (2005) 700-713
13. - phase nor the vrg6 locus of Bordetella pertussis is required for respiratory infection in mice. Infect. Immun. 66 (1998) 2762-2768
14. Weiss A.A., Melton A.R., Walker K.E., Andraos-Selim C., and Meidl J.J. Use of the promoter fusion transposon Tn5 lac to identify mutations in Bordetella pertussis vir-regulated genes. Infect. Immun. 57 (1989) 2674-2682
15. Calder M.A., Duguid J.P., Elias-Jones T.F., Fallon R.J., Gillies R.R., Green D.M., Grist N.R., Lawson J.H., Love W.C., McKenzie P., Pinkerton I.W., Ross C.A., Sangster G., and Wilson A.M. What causes whooping-cough?. Lancet 21 (1970) 1079-1083
16. Lawson M.G. Modified technique for staining capsules of Hemophilus pertussis. J. Lab. Clin. Med. (1939) 435-438
17. - mutants. FEMS Microbiol. Lett. 133 (1995) 21-28
18. Parkhill J., Sebaihia M., Preston A., Murphy L.D., Thomson N., Harris D.E., Holden M.T., Churcher C.M., Bentley S.D., Mungall K.L., Cerdeno-Tarraga A.M., Temple L., James K., Harris B., Quail M.A., Achtman M., Atkin R., Baker S., Basham D., Bason N., Cherevach I., Chillingworth T., Collins M., Cronin A., Davis P., Doggett J., Feltwell T., Goble A., Hamlin N., Hauser H., Holroyd S., Jagels K., Leather S., Moule S., Norberczak H., O'Neil S., Ormond D., Price C., Rabbinowitsch E., Rutter S., Sanders M., Saunders D., Seeger K., Sharp S., Simmonds M., Skelton J., Squares R., Squares S., Stevens K., Unwin L., Whitehead S., Barrell B.G., and Maskell D.J. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35 (2003) 32-40
19. Hot D., Antoine R., Renauld-Mongenie G., Caro V., Hennuy B., Levillain E., Huot L., Wittmann G., Poncet D., Jacob-Dubuisson F., Guyard C., Rimlinger F., Aujame L., Godfroid E., Guiso N., Quentin-Millet M.J., Lemoine Y., and Locht C. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol. Genet. Genomics 269 (2003) 475-486
20. Antoine R., and Locht C. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect. Immun. 58 (1990) 1518-1526
21. Menozzi F.D., Gantiez C., and Locht C. Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica. Infect. Immun. 59 (1991) 3982-3988
22. Stibitz S. Use of conditionally counterselectable suicide vectors for allelic exchange. Methods Enzymol. 235 (1994) 458-465
23. Karlyshev A.V., McCrossan M.V., and Wren B.W. Demonstration of polysaccharide capsule in Campylobacter jejuni using electron microscopy. Infect. Immun. 69 (2001) 5921-5924
24. Tsang R.S.W., and Chau P.Y. Production of Vi antibodies and their application as diagnostic reagents. J. Clin. Microbiol. 25 (1987) 531-535
25. Reimann K., Heise H., and Blom J. Attempts to demonstrate a polysaccharide capsule in Neisseria gonorrhoeae. APMIS 96 (1988) 735-740
26. Gunther H., Rosner H., Godat M., and Erler M. Electron microscopic visualization of the capsule of Pasteurella multocida. Acta Histochem. Suppl. 33 (1986) 293-296
27. Fernandez R.C., and Weiss A.A. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrob. Agents Chemother. 40 (1996) 1041-1043
28. Barnes M.G., and Weiss A.A. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect. Immun. 69 (2001) 3067-3072
29. Marr N., Luu R.A., and Fernandez R.C. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing. J. Infect. Dis. 195 (2007) 585-588
30. Winter S.E., Raffatellu M., Wilson R.P., Russmann H., and Baumler A.J. The Salmonella enterica serotype Typhi regulator TviA reduces IL-8 production in intestinal epithelial cells by repressing flagellin secretion. Cell. Microbiol. 10 (2007) 247-261